We are live on ! Find out more
X

Xponance Portfolio holdings

AUM $16.3B
1-Year Est. Return 44.61%
This Fund
S&P 500
This Quarter Est. Return
+6.44%
1 Year Est. Return
+44.61%
3 Year Est. Return
+143.93%
5 Year Est. Return
+195.59%
10 Year Est. Return
+501.04%
AUM
$10.4B
AUM Growth
+$576M
Cap. Flow
+$80.3M
Cap. Flow %
0.78%
Top 10 Hldgs %
38.6%
Holding
1,407
New
91
Increased
858
Reduced
433
Closed
18
Avg Time Held
12.2 quarters
Top 10 Avg Time Held
13 quarters
Top 20 Avg Time Held
11.3 quarters

Top Buys

Rank Stock Value
1
AVGO icon
Broadcom
AVGO
+$12.5M
2
GOOGL icon
Alphabet (Google) Class A
GOOGL
+$12.5M
3
META icon
Meta Platforms (Facebook)
META
+$8.69M
4
V icon
Visa
V
+$8.21M
5
AMZN icon
Amazon
AMZN
+$6.1M

Sector Composition

Rank Sector Weight
1 Technology 35.83%
2 Consumer Discretionary 11.41%
3 Financials 11.04%
4 Healthcare 10.64%
5 Communication Services 9.77%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow Held Since
ELV icon
76
Elevance Health
ELV
$89.5B
$21.9M 0.21%
42,106
-1,906
-4% -$1.02M
2020 Q2
17 quarters
SHW icon
77
Sherwin-Williams
SHW
$77.5B
$21.9M 0.21%
57,342
+5,551
+11% +$1.94M
2020 Q2
17 quarters
T icon
78
AT&T
T
$152B
$21.7M 0.21%
988,000
+23,167
+2% +$461K
2020 Q2
17 quarters
MCO icon
79
Moody's
MCO
$80.4B
$21.5M 0.21%
45,206
-6,783
-13% -$3.14M
2020 Q2
17 quarters
RTX icon
80
RTX Corp
RTX
$251B
$21.4M 0.21%
177,010
+4,174
+2% +$476K
2020 Q2
17 quarters
NKE icon
81
Nike
NKE
$51.6B
$21.2M 0.21%
240,234
+944
+0.4% +$74K
2020 Q2
17 quarters
MRSH icon
82
Marsh
MRSH
$83.9B
$20.8M 0.2%
93,035
-11,173
-11% -$2.48M
2020 Q2
17 quarters
SYK icon
83
Stryker
SYK
$106B
$20.6M 0.2%
56,992
+520
+0.9% +$179K
2020 Q2
17 quarters
ZTS icon
84
Zoetis
ZTS
$30.9B
$20.3M 0.2%
104,125
+6,579
+7% +$1.21M
2020 Q2
17 quarters
SNPS icon
85
Synopsys
SNPS
$97.7B
$20.1M 0.19%
39,637
-353
-0.9% -$189K
2020 Q2
17 quarters
HON icon
86
Honeywell
HON
$65.8B
$19.7M 0.19%
100,991
+1,374
+1% +$266K
2020 Q2
17 quarters
CDNS icon
87
Cadence Design Systems
CDNS
$97.2B
$19.6M 0.19%
72,192
-6,276
-8% -$1.74M
2020 Q2
17 quarters
BLK icon
88
Blackrock
BLK
$168B
$19.4M 0.19%
20,404
+118
+0.6% +$102K
2020 Q2
17 quarters
FISV icon
89
Fiserv Inc
FISV
$24.3B
$19.1M 0.18%
106,238
-1,016
-0.9% -$168K
2020 Q2
17 quarters
ETN icon
90
Eaton
ETN
$167B
$18.8M 0.18%
56,792
+1,093
+2% +$334K
2020 Q2
17 quarters
WM icon
91
Waste Management
WM
$83.5B
$18.5M 0.18%
89,232
-886
-1% -$185K
2020 Q2
17 quarters
MS icon
92
Morgan Stanley
MS
$298B
$18.4M 0.18%
176,957
+2,320
+1% +$234K
2020 Q2
17 quarters
CMG icon
93
Chipotle Mexican Grill
CMG
$40B
$17.8M 0.17%
308,326
-4,092
-1% -$227K
2020 Q2
17 quarters
BSX icon
94
Boston Scientific
BSX
$61.9B
$17.5M 0.17%
208,458
+4,247
+2% +$335K
2020 Q2
17 quarters
ADI icon
95
Analog Devices
ADI
$197B
$17M 0.16%
73,823
+6,115
+9% +$1.38M
2020 Q2
17 quarters
CL icon
96
Colgate-Palmolive
CL
$70.4B
$16.9M 0.16%
163,159
-28,960
-15% -$2.95M
2020 Q2
17 quarters
C icon
97
Citigroup
C
$217B
$16.9M 0.16%
270,136
+6,483
+2% +$401K
2020 Q2
17 quarters
PLD icon
98
Prologis
PLD
$123B
$16.8M 0.16%
132,688
+3,920
+3% +$486K
2020 Q2
17 quarters
BMY icon
99
Bristol-Myers Squibb
BMY
$121B
$16.7M 0.16%
322,569
+5,188
+2% +$243K
2020 Q2
17 quarters
PLTR icon
100
Palantir
PLTR
$502B
$16.6M 0.16%
447,470
+96,621
+28% +$2.97M
2021 Q2
13 quarters

Similar funds

Xponance's Q3 2024 Portfolio in Review

As of Q3 2024, Xponance held 1,407 positions worth $10.4B, up 5.9% from $9.78B the previous quarter. Its ten largest holdings account for 39% of the portfolio.

Xponance's Q3 2024 filing shows 91 new, 858 increased, 433 reduced and 18 closed positions. Its largest new stake was Smurfit Westrock: 106,066 shares worth $5.24M. The largest sale was Eli Lilly, an estimated $7.31M.

By sector, the portfolio is most concentrated in Technology at 36% of assets, down from 37% a quarter earlier, followed by Consumer Discretionary and Financials.

  • Xponance's largest Q3 2024 buy was Smurfit Westrock: 106,066 shares worth $5.24M.
  • Xponance added most to Broadcom in Q3 2024, an estimated $12.5M increase.
  • Xponance's biggest Q3 2024 reduction was Eli Lilly, cutting an estimated $7.31M.
  • Xponance fully exited Invesco S&P 500 Concentrated QVM ETF in Q3 2024, selling an estimated $3.61M.
  • Xponance's ten largest holdings make up 39% of its $10.4B portfolio in Q3 2024.
  • Xponance opened 91 new positions and closed 18 in Q3 2024.
  • Xponance's portfolio value rose 5.9% quarter-over-quarter to $10.4B.

Based on Xponance's 13F filing for Q3 2024, filed 12 Nov 2024.